Ramadan Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ramadan Ali has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed M. El-Wekil
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt
8 shared publications Hassan Refat H. Ali
7 shared publicationsSayed M. Derayea
7 shared publicationsAdel A. Marzouk
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt
4 shared publicationsAshraf M. Mahmoud
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia
4 shared publications- Jürgen Burhenne
Heidelberg University
4 shared publications
Latest Publications
- Open Access
- 5 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (26) , 23625-23636
Ag–Sn@MOFs heterostructure enables ultrasensitive voltammetric determination of vismodegib in serum and urine
Accurate measurement of vismodegib (VIS) is essential for pharmacokinetic profiling, individualized dosing, and therapeutic drug monitoring. In this work, we report an Ag–Sn@MOFs heterostructure as a sustainable composite sensing interface for highly sensitive voltammetric determination of VIS. A simple solvothermal – reduction route yielded an integrated nanocomposite that synergistically combines the high conductivity and electrocatalytic activity of Ag nanoparticles with the high-surface-area, defect-rich architecture of Sn@MOFs. Multimodal characterization verified uniform immobilization of Ag nanoparticles on the Sn@MOFs scaffold and the formation of a stable, conductive interface. Owing to accelerated charge-transfer kinetics and enhanced VIS oxidation, the modified electrode delivered an ultralow limit of detection of 0.006 nM, high sensitivity of 14.782 µA nM−1 cm−2, and a wide linear range of 0.05–500 nM (R2 = 0.9974). Importantly, the sensor maintained excellent accuracy in complex matrices, providing recoveries of 95.6–107.6% with precision ≤3.29% RSD in spiked human urine and serum, demonstrating strong matrix tolerance. The combination of scalable, low-toxicity fabrication with robust selectivity and stability highlights the platform's potential for VIS therapeutic monitoring, pharmacokinetic studies, and translation toward point-of-care diagnostics.
- 5 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (26) , 23625-23636
Open AccessAg–Sn@MOFs heterostructure enables ultrasensitive voltammetric determination of vismodegib in serum and urine
Accurate measurement of vismodegib (VIS) is essential for pharmacokinetic profiling, individualized dosing, and therapeutic drug monitoring. In this work, we report an Ag–Sn@MOFs heterostructure as a sustainable composite sensing interface for highly sensitive voltammetric determination of VIS. A simple solvothermal – reduction route yielded an integrated nanocomposite that synergistically combines the high conductivity and electrocatalytic activity of Ag nanoparticles with the high-surface-area, defect-rich architecture of Sn@MOFs. Multimodal characterization verified uniform immobilization of Ag nanoparticles on the Sn@MOFs scaffold and the formation of a stable, conductive interface. Owing to accelerated charge-transfer kinetics and enhanced VIS oxidation, the modified electrode delivered an ultralow limit of detection of 0.006 nM, high sensitivity of 14.782 µA nM−1 cm−2, and a wide linear range of 0.05–500 nM (R2 = 0.9974). Importantly, the sensor maintained excellent accuracy in complex matrices, providing recoveries of 95.6–107.6% with precision ≤3.29% RSD in spiked human urine and serum, demonstrating strong matrix tolerance. The combination of scalable, low-toxicity fabrication with robust selectivity and stability highlights the platform's potential for VIS therapeutic monitoring, pharmacokinetic studies, and translation toward point-of-care diagnostics.
- Open Access
- 24 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (24) , 22144-22157
A robust dual-readout ratiometric assay for dopamine based on NiMn 2 O 4 -catalyzed DHNP fluorophore conversion
The dual enzyme-mimetic NiMn 2 O 4 nanoflower platform enabled reliable DA detection through a self-calibrated ratiometric fluorescence–colorimetric strategy.
- 24 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (24) , 22144-22157
Open AccessA robust dual-readout ratiometric assay for dopamine based on NiMn 2 O 4 -catalyzed DHNP fluorophore conversion
The dual enzyme-mimetic NiMn 2 O 4 nanoflower platform enabled reliable DA detection through a self-calibrated ratiometric fluorescence–colorimetric strategy.
- 30 March 2026
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 18 (14) , 2981-2990
A novel NIR fluorescent probe based on p -mercaptophenylboronic acid-functionalized copper nanoclusters for capmatinib quantification
A red-emitting p -MPBA@CuNC “turn-off” fluorescent probe was developed for highly sensitive and selective capmatinib detection.
- 30 March 2026
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 18 (14) , 2981-2990
A novel NIR fluorescent probe based on p -mercaptophenylboronic acid-functionalized copper nanoclusters for capmatinib quantification
A red-emitting p -MPBA@CuNC “turn-off” fluorescent probe was developed for highly sensitive and selective capmatinib detection.
- 1 September 2019
- Published by Elsevier in Microchemical Journal
- Vol. 149
Investigating erythrosine B as a fluorimetric probe for the determination of benzimidazole drugs via facile complexation reaction
- 1 September 2019
- Published by Elsevier in Microchemical Journal
- Vol. 149
Investigating erythrosine B as a fluorimetric probe for the determination of benzimidazole drugs via facile complexation reaction
- 1 July 2019
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 171, 104-110
A clinical study for the evaluation of pharmacokinetic interaction between daclatasvir and fluoxetine
- 1 July 2019
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 171, 104-110
A clinical study for the evaluation of pharmacokinetic interaction between daclatasvir and fluoxetine
- 1 June 2019
- Published by Elsevier in Microchemical Journal
- Vol. 147, 1133-1140
Facile synthesis of novel nanocomposite prepared from spinel copper ferrite and reduced graphene oxide in the presence of anti-fouling agent diethyl ammonium acid sulphate for ultrasensitive detection of rosuvastatin in human plasma
- 1 June 2019
- Published by Elsevier in Microchemical Journal
- Vol. 147, 1133-1140
Facile synthesis of novel nanocomposite prepared from spinel copper ferrite and reduced graphene oxide in the presence of anti-fouling agent diethyl ammonium acid sulphate for ultrasensitive detection of rosuvastatin in human plasma
- 1 May 2019
- Published by Elsevier in Microchemical Journal
- Vol. 146, 864-871
A reductant colorimetric method for the rapid detection of certain cephalosporins via the production of gold and silver nanoparticles
- 1 May 2019
- Published by Elsevier in Microchemical Journal
- Vol. 146, 864-871
A reductant colorimetric method for the rapid detection of certain cephalosporins via the production of gold and silver nanoparticles
- 1 March 2019
- Published by Elsevier in Microchemical Journal
- Vol. 145, 672-675
Xanthene based spectroscopic probe for the analysis of HCV antiviral, daclatasvir dihydrochloride, through feasible complexation reaction
- 1 March 2019
- Published by Elsevier in Microchemical Journal
- Vol. 145, 672-675
Xanthene based spectroscopic probe for the analysis of HCV antiviral, daclatasvir dihydrochloride, through feasible complexation reaction